[Trilostane therapy in patients with hypercorticism].
D015096:3-Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors*; D000328:Adult; D003480:Cushing Syndrome / Q000188:drug therapy*; D013196:Dihydrotestosterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D006929:Hyperaldosteronism / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010086:Oxidative Phosphorylation Coupling Factors / Q000627:therapeutic use*
D010086:Oxidative Phosphorylation Coupling Factors; D013196:Dihydrotestosterone; D015096:3-Hydroxysteroid Dehydrogenases; C009954:trilostane; D006854:Hydrocortisone